Skip to main content
Publications
Fernandez-Barres S, Romaguera D, Valvi D, Martinez D Mediterranean dietary pattern in pregnant women and offspring risk of overweight and abdominal obesity in early childhood: the INMA birth cohort study 10.1111/ijpo.12092
Abdul-Jawad Altisent O, Durand E, Munoz-Garcia AJ, Nombela-Franco L, Cheema A, Kefer J, Gutierrez E, Benitez LM, Amat-Santos IJ, Serra V, Eltchaninoff H, Alnasser SM, Elizaga J, Dager A, Garcia Del Blanco B, Ortas-Nadal MDR, Marsal JR Reply: antithrombotic regimen in post-TAVR atrial fibrillation: not an easy decision 10.1016/j.jcin.2016.09.038
Strober B, Blauvelt A, Zhao Y, Milutinovic M, Mollon P, You R, Sherif B Secukinumab provides better relief from psoriasis-related pain, itching, and scaling than ustekinumab
Tyring S, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Sherif B Secukinumab provides better relief from quality-of-life impact than etanercept in moderate to severe psoriasis
Sofen H, Korman N, Rich P, Fretzin S, Zhao Y, Herrera V, Sherif B McLeod L Secukinumab provides better relief from quality-of-life impact than placebo in moderate to severe psoriasis
Blauvelt A, Korman N, Mollon P, Zhao Y, Milutinovic M, You R, Sherif B Secukinumab provides faster and better quality of life impact than ustekinumab in psoriasis
Tyring S, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Sherif B Secukinumab provides more effective relief from skin-related quality-of-life impact than etanercept in moderate to severe psoriasis
Sofen H, Korman N, Rich P, Fretzin S, Zhao Y, Herrera V, Sherif B McLeod L Secukinumab provides more effective relief from skin-related quality-of-life impact than placebo in moderate to severe psoriasis
Tyring S, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Sherif B Secukinumab provides more effective relief from skin-related quality-of-life impact than etanercept in moderate to severe psoriasis
Sofen H, Korman N, Rich P, Fretzin S, Zhao Y, Herrera V, Sherif B McLeod L Secukinumab provides more effective relief from skin-related quality-of-life impact than placebo in moderate to severe psoriasis
Strober B, Blauvelt A, Zhao Y, Milutinovic M, Mollon P, You R, Sherif B Secukinumab treatment provides more effective relief from patient-reported psoriasis-related pain, itching, and scaling than ustekinumab
Blauvelt A, Korman N, Mollon P, Zhou Y, Milutinovic M, You R, Sherif B Secukinumab treatment provides faster and more effective relief from patient-reported quality of life impact than ustekinumab in subjects with moderate to severe plaque psoriasis
Police RL, Trask PC, Wang J, Olivares R, Khan S Colosia A Njue A Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysis 10.1177/1078155215603230
Tyring S, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Sherif B Secukinumab provides more effective relief from skin-related quality-of-life impact than etanercept in moderate to severe psoriasis
Sofen H, Korman N, Rich P, Fretzin S, Zhao Y, Herrera V, Sherif B McLeod L Secukinumab provides more effective relief from skin-related quality-of-life impact than placebo in moderate to severe psoriasis
Vender R, Leonardi C, Puig L, Ziv M, Zhou Y, Gilloteau I, Sherif B McLeod LD Secukinumab provides greater cumulative 52-week skin clearance and quality of life benefit in patients with moderate-to-severe plaque psoriasis than ustekinumab: an area under the curve analysis
Blauvelt A, Mehlis S, Vanaclocha F, Vender R, Zhao Y, Gilloteau I, Davenport E Secukinumab provides greater 52-week sustained relief from dermatology-related quality of life impact on clothing choice and sexual function than ustekinumab
Luo C, Sun J, Liu D, Sun B, Miao L, Musetti S Self-assembled redox dual-responsive prodrug-nanosystem formed by single thioether-bridged paclitaxel-fatty acid conjugate for cancer chemotherapy 10.1021/acs.nanolett.6b01632
Stempel DA, Szefler SJ, Pedersen S, Zeiger RS, Yeakey AM, Lee LA, Liu AH, Mitchell H, Kral KM, Raphiou IH, Prillaman BA Safety of adding salmeterol to fluticasone propionate in children with asthma 10.1056/NEJMoa1606356
Afonso A, Schmiedl S, Becker C, Tcherny-Lessenot S, Primatesta P, Plana E A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction
Abdul-Jawad Altisent O, Durand E, Munoz-Garcia AJ, Nombela-Franco L, Cheema A, Kefer J, Gutierrez E, Benitez LM, Amat-Santos IJ, Serra V, Eltchaninoff H, Alnasser SM, Elizaga J, Dager A, Garcia Del Blanco B, Ortas-Nadal Mdel R, Marsal JR Warfarin and antiplatelet therapy versus Warfarin alone for treating patients with atrial fibrillation undergoing transcatheter aortic valve replacement 10.1016/j.jcin.2016.06.025
O'Connor G, Pinero Casas M, Basagana X, Vicente ML, Davand P, Torrent M, Martinez-Murciano D Garcia-Esteban R Television viewing duration during childhood and long-association with adolescent neuropsychological outcomes 10.1016/j.pmedr.2016.08.013
Nabhan C, Zhou X Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States 10.1002/ajh.24401
Plana E Fortuny J Gilsenan AW Rebordosa C Ziemiecki R An algorithm to identify duplicate patients when pooling aggregate data from two primary care databases in the United Kingdom 10.1002/pds
Robinson O, Martinez D The association between passive and active tobacco smoke exposure and child weight status among Spanish children 10.1002/oby.21558
Manzano-Salgado CB, Casas M, Lopez-Espinosa MJ, Ballester F, Martinez D Variability of perfluoroalkyl substance concentrations in pregnant women by socio-demographic and dietary factors in a Spanish birth cohort 10.1016/j.envint.2016.04.004
Vardavas CI, Hohmann C, Patelarou E, Martinez D The independent role of prenatal and postnatal exposure to active and passive smoking on the development of early wheeze in children 10.1183/13993003.01016-2015
Alcubierre N, Navarrete-Muñoz EM, Rubinat E, Falguera M, Valls J, Traveset A, Vilanova MB, Marsal JR Association of low oleic intake acid with diabetic retinopathy in type 2 diabetic patients: a case-control study 10.1186/s12986-016-0099-5
Abdul-Jawad Altisent O, Ferreira-Gonzalez I, Marsal JR Neurological damage after transcatheter aortic valve implantation compared with surgical aortic valve replacement in intermediate risk patients 10.1007/s00392-015-0946-9
Strober B, Blauvelt A, Zhao Y, Milutinovic M, Mollon P, You R, Sherif B Secukinumab treatment provides more effective relief from patient-reported psoriasis-related pain, itching, and scaling than ustekinumab
Strober B, Blauvelt A, Zhao Y, Milutinovic M, Mollon P, You R, Sherif B Secukinumab treatment provides more effective relief from patient-reported psoriasis-related pain, itching, and scaling than ustekinumab
Blauvelt A, Korman N, Mollon P, Zhao Y, Milutinovic M, You R, Sherif B Secukinumab treatment provides faster and more effective relief from patient-reported quality-of- life impact than ustekinumab in subjects with moderate to severe plaque psoriasis
Blauvelt A, Korman N, Mollon P, Zhao Y, Milutinovic M, You R, Sherif B Secukinumab treatment provides faster and more effective relief from patient-reported quality of life impact than ustekinumab in subjects with moderate to severe plaque psoriasis
